Marc Dunoyer - 16 Jun 2021 Form 4 Insider Report for Orchard Therapeutics plc

Role
Director
Signature
/s/ Frank Thomas, as attorney-in-fact
Issuer symbol
N/A
Transactions as of
16 Jun 2021
Net transactions value
$0
Form type
4
Filing time
17 Jun 2021, 17:01:09 UTC
Next filing
08 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORTX Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 16 Jun 2021 Ordinary Shares 40,000 $4.79 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 All of the shares subject to this option vest upon the earlier to occur of June 16, 2022 or the date of the 2022 Annual General Meeting of the Company.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.